serine and everolimus

serine has been researched along with everolimus in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beggs, RE; Bose, S; Crapuchettes, ME; D'Abronzo, LS; deVere White, RW; Durbin-Johnson, BP; Ghosh, PM; Melgoza, FU; Mudryj, M; Siddiqui, S; Tepper, CG; Vinall, RL	1
Bedja, D; Chen, A; Dunkerly-Eyring, BL; Holewinski, RJ; Kass, DA; Kokkonen-Simon, KM; Lee, DI; Nakamura, T; Oeing, CU; Patel, CH; Powell, JD; Ranek, MJ; Sasaki, M; Van Eyk, JE; Vera, MP; Zhu, G	1

Other Studies

2 other study(ies) available for serine and everolimus

Article	Year
The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer. Oncogene, 2017, 11-16, Volume: 36, Issue:46 Topics: Anilides; Aniline Compounds; Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Line, Tumor; Eukaryotic Initiation Factor-4E; Everolimus; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice, Nude; Nitriles; Phosphorylation; Prostatic Neoplasms, Castration-Resistant; Protein Serine-Threonine Kinases; Purines; Receptors, Androgen; Serine; Sirolimus; TOR Serine-Threonine Kinases; Tosyl Compounds; Xenograft Model Antitumor Assays	2017
PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress. Nature, 2019, Volume: 566, Issue:7743 Topics: Animals; Autophagy; Cells, Cultured; Cyclic GMP-Dependent Protein Kinases; Disease Progression; Enzyme Activation; Everolimus; Female; Gene Knock-In Techniques; Heart Diseases; HEK293 Cells; Humans; Hypertrophy; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mutation; Myocytes, Cardiac; Phosphorylation; Phosphoserine; Pressure; Rats; Rats, Wistar; Serine; Tuberous Sclerosis Complex 2 Protein	2019

Article

Year

The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer.

Oncogene, 2017, 11-16, Volume: 36, Issue:46

Topics: Anilides; Aniline Compounds; Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Cell Line, Tumor; Eukaryotic Initiation Factor-4E; Everolimus; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice, Nude; Nitriles; Phosphorylation; Prostatic Neoplasms, Castration-Resistant; Protein Serine-Threonine Kinases; Purines; Receptors, Androgen; Serine; Sirolimus; TOR Serine-Threonine Kinases; Tosyl Compounds; Xenograft Model Antitumor Assays

2017

PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress.

Nature, 2019, Volume: 566, Issue:7743

Topics: Animals; Autophagy; Cells, Cultured; Cyclic GMP-Dependent Protein Kinases; Disease Progression; Enzyme Activation; Everolimus; Female; Gene Knock-In Techniques; Heart Diseases; HEK293 Cells; Humans; Hypertrophy; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Mutation; Myocytes, Cardiac; Phosphorylation; Phosphoserine; Pressure; Rats; Rats, Wistar; Serine; Tuberous Sclerosis Complex 2 Protein

2019